These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22169097)

  • 1. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
    Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
    Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.
    Liu R; Zhang C; Hu Z; Li G; Wang C; Yang C; Huang D; Chen X; Zhang H; Zhuang R; Deng T; Liu H; Yin J; Wang S; Zen K; Ba Y; Zhang CY
    Eur J Cancer; 2011 Mar; 47(5):784-91. PubMed ID: 21112772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
    Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
    Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
    Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
    Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
    J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
    Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
    Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
    Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs in plasma of patients with gastric cancers.
    Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
    Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.
    Zhao A; Li G; Péoc'h M; Genin C; Gigante M
    Exp Mol Pathol; 2013 Feb; 94(1):115-20. PubMed ID: 23064048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA expression profile in undifferentiated gastric cancer.
    Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
    Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
    Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
    J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.